Effect of Magnesium Sulfate on Ventricular Rate Control in Atrial Fibrillation

Janet V. Hays, James K. Gilman, Bernard J. Rubal

Research output: Contribution to journalArticlepeer-review

36 Scopus citations

Abstract

Study objectives: The objectives of this study were to assess the efficacy of parenteral magnesium sulfate (MgSO4), digoxin, and combined MgSO4 -digoxin therapies in acutely lowering ventricular rates in patients with newly recognized atrial fibrillation. Design: A randomized, double-blinded, placebo-controlled clinical study. Setting: US Army tertiary care facility. Participants: Fifteen adults (mean age, 62±19 years) presenting with newly recognized atrial fibrillation and rapid ventricular rate (more than 99). Interventions: Patients were given an initial parenteral MgSO4 bolus with continuous infusion or placebo. After 30 minutes, all patients were given 0.5 mg IV digoxin and followed for 3.5 hours. Measurements and main results: Ventricular rates were obtained at baseline, every 5 minutes for the first 30 minutes, and then every 30 minutes for 3.5 hours. At 5 minutes, ventricular rates decreased 16±7% (P <.02) with MgSO4 ; this was comparable with rate control with digoxin (18±9%) at 4 hours. Rate control tended (26±7%) to improve with combined therapy. Conclusion: Parenteral MgSO4 may be useful in the acute management of rapid ventricular rates in patients with atrial fibrillation. [Hays JV, Gilman JK, Rubal BJ: Effect of magnesium sulfate on ventricular rate control in atrial fibrillation. Ann Emerg Med July 1994;24:61-64.]

Original languageEnglish (US)
Pages (from-to)61-64
Number of pages4
JournalAnnals of Emergency Medicine
Volume24
Issue number1
DOIs
StatePublished - Jan 1 1994
Externally publishedYes

ASJC Scopus subject areas

  • Emergency Medicine

Fingerprint Dive into the research topics of 'Effect of Magnesium Sulfate on Ventricular Rate Control in Atrial Fibrillation'. Together they form a unique fingerprint.

Cite this